Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9923834 | 0.92 | TSHR (0.68) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL271812 | 0.91 | TSHR (0.64) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL22561253 | 0.89 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDDGKA | |
| SCHEMBL22561246 | 0.89 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDDGKA | |
| SCHEMBL276446 | 0.89 | TSHR (0.73) | TSHRALDH1A1CYP3A4HPGDDGKA | |
| SCHEMBL13135371 | 0.88 | TSHR (0.47) | TSHRALDH1A1CYP3A4HPGDDGKA | |
| SCHEMBL12225909 | 0.88 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDDGKA | |
| SCHEMBL19934814 | 0.87 | TSHR (0.55) | TSHRALDH1A1CYP3A4HPGDDGKA | |
| SCHEMBL295847 | 0.87 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL11233083 | 0.87 | TSHR (0.76) | TSHRALDH1A1CYP3A4HPGDDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8177897-B2 | Phase change inks containing graphene-based carbon allotrope colorants | XEROX CORPORATION (US) | 2012-05-15 | — | — | US | disclosed |
| US-8142557-B2 | Radiation curable ink containing gellant and radiation curable wax | XEROX CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| US-20100124611-A1 | Phase Change Inks Containing Graphene-Based Carbon Allotrope Colorants | XEROX CORPORATION (US) | 2010-05-20 | — | — | US | disclosed |
| US-20100116424-A1 | ORGANIC PHASE CHANGE CARRIERS CONTAINING NANOPARTICLES, PHASE CHANGE INKS INCLUDING SAME AND METHODS FOR MAKING SAME | XEROX CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100055407-A1 | Ultra-Violet Curable Gellant Inks For Creating Tactile Text And Images For Packaging Applications | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100055484-A1 | Ultra-Violet Curable Gellant Inks For Three-Dimensional Printing And Digital Fabrication Applications | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20090317559-A1 | METHOD OF CONTROLLING GLOSS IN UV CURABLE OVERCOAT COMPOSITIONS | XEROX CORPORATION (US) | 2009-12-24 | — | — | US | disclosed |
| US-20080000384-A1 | RADIATION CURABLE INK CONTAINING GELLANT AND RADIATION CURABLE WAX | XEROX CORPORATION (US) | 2008-01-03 | — | — | US | disclosed |
| US-7259275-B2 | Method for preparing curable amide gellant compounds | XEROX CORPORATION (US) | 2007-08-21 | — | — | US | disclosed |
| US-20070123724-A1 | Method for preparing curable amide gellant compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123724-A1 | Method for preparing curable amide gellant compounds | ODC1, INO80C, AOC1 | TSHR 2143/4885ALDH1A1 526/4885CYP3A4 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.